| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
TEM
Tempus AI, Inc. Class A
|
Jun 01, 2026 | BUY |
Strong Buy
+33.8% avg upside
19 analysts
|
$60.00
17.93% Upside
|
-4.2% |
|
ILMN
Illumina
|
Jun 01, 2026 | BUY |
Buy
-10.0% avg upside
30 analysts
|
$180.00
11.13% Upside
|
-3.2% |
|
GH
Guardant Health
|
May 28, 2026 | BUY |
Strong Buy
-5.8% avg upside
30 analysts
|
$135.00
2.54% Upside
|
-3.1% |
|
GRAL
GRAIL Inc
|
May 26, 2026 | BUY |
Buy
+3.6% avg upside
8 analysts
|
$75.00
17.60% Upside
|
-15.5% |
|
TWST
Twist Bioscience
|
May 22, 2026 | BUY |
Strong Buy
-25.5% avg upside
14 analysts
|
$60.00
31.40% Downside
|
+40.2% |
|
BLLN
BillionToOne, Inc. Class A
|
May 13, 2026 | BUY |
Strong Buy
+16.4% avg upside
8 analysts
|
$120.00
14.14% Upside
|
+11.6% |
|
MRVI
Maravai Lifesciences Holdings
|
May 11, 2026 | HOLD |
Strong Buy
+175.0% avg upside
17 analysts
|
— | -12.4% |
|
WAT
Waters
|
May 11, 2026 | BUY |
Strong Buy
+3.5% avg upside
30 analysts
|
$440.00
23.77% Upside
|
+2.8% |
|
CSTL
Castle Biosciences
|
May 07, 2026 | BUY |
Strong Buy
+98.2% avg upside
9 analysts
|
$47.00
122.51% Upside
|
-0.6% |
|
PSNL
Personalis
|
May 07, 2026 | BUY |
Strong Buy
+13.8% avg upside
11 analysts
|
$13.00
23.35% Upside
|
+76.0% |
|
BRKR
Bruker
|
May 06, 2026 | BUY |
Buy
-7.0% avg upside
22 analysts
|
$50.00
12.65% Downside
|
+29.4% |
|
VCYT
Veracyte
|
May 06, 2026 | BUY |
Strong Buy
-19.0% avg upside
17 analysts
|
$45.00
16.04% Downside
|
-6.6% |
|
ADPT
Adaptive Biotechnologies
|
May 06, 2026 | BUY |
Strong Buy
+20.0% avg upside
14 analysts
|
$21.00
19.88% Upside
|
+22.0% |
|
SOPH
SOPHiA GENETICS
|
May 06, 2026 | BUY |
Strong Buy
+75.8% avg upside
7 analysts
|
$7.00
28.13% Upside
|
-5.6% |
|
CYRX
CryoPort
|
May 05, 2026 | BUY |
Strong Buy
-3.8% avg upside
15 analysts
|
$12.00
19.99% Downside
|
+7.8% |
|
WGS
GeneDx Holdings
|
May 04, 2026 | BUY |
Strong Buy
+35.9% avg upside
9 analysts
|
$70.00
18.58% Upside
|
-9.7% |
|
NAUT
Nautilus Biotechnolgy
|
Apr 28, 2026 | BUY |
Strong Buy
+404.4% avg upside
5 analysts
|
$4.00
75.39% Upside
|
-7.7% |
|
NEOG
Neogen
|
Apr 27, 2026 | BUY |
Buy
+148.1% avg upside
6 analysts
|
$12.00
28.85% Upside
|
-8.0% |
|
DHR
Danaher
|
Apr 21, 2026 | BUY |
Strong Buy
+21.8% avg upside
45 analysts
|
$235.00
32.74% Upside
|
-6.8% |
|
NTRA
Natera
|
Feb 26, 2026 | BUY |
Strong Buy
+7.6% avg upside
26 analysts
|
$270.00
16.74% Upside
|
+4.8% |
|
RGEN
Repligen
|
Feb 24, 2026 | HOLD |
Strong Buy
+28.3% avg upside
25 analysts
|
— | -9.2% |
|
PACB
Pacific Biosciences
|
Feb 12, 2026 | HOLD |
Buy
+214.0% avg upside
14 analysts
|
— | -39.1% |
|
NEO
NeoGenomics
|
Oct 28, 2025 | HOLD |
Strong Buy
+40.2% avg upside
17 analysts
|
— | +12.4% |
|
RVTY
Revvity
|
Oct 27, 2025 | HOLD |
Buy
+5.5% avg upside
23 analysts
|
— | +0.8% |
|
DE:SRT3
Sartorius
|
Oct 16, 2025 | BUY |
Buy
+26.8% avg upside
17 analysts
|
$263.00
21.05% Upside
|
· |
|
CAI
Caris Life Sciences, Inc.
|
Jul 13, 2025 | BUY |
Strong Buy
+54.5% avg upside
20 analysts
|
$32.00
73.32% Upside
|
-40.5% |
|
MYGN
Myriad Genetics
|
Apr 08, 2025 | HOLD |
Hold
+315.3% avg upside
24 analysts
|
— | -49.4% |
|
TXG
10x Genomics
|
Feb 23, 2025 | HOLD |
Buy
-26.8% avg upside
18 analysts
|
— | +181.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.